AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial
AC Immune show first images from alpha-synuclein PET
AC Immune Alzheimer's Drug Reduces Cognitive Decline but Misses Functional Endpoints | BioSpace
Who is AC Immune? A cutting-edge company with a robust pipeline
Precision medicine for neurodegenerative diseases | AC Immune SA
AC Immune – Swiss Biotech
AC Immune Announces Strategic Acquisition of
Precision medicine for neurodegenerative diseases | AC Immune SA
AC-Immune-2018 - SVB Securities
Precision medicine for neurodegenerative diseases | AC Immune SA
Jabbing at Alzheimer's: AC Immune Takes Precision Approach to Vaccines
Delivering breakthrough therapies for neurodegenerative diseases
Genentech, J&J partner AC Immune files IPO for Alzheimer's pipeline | Fierce Biotech
AC Immune (@AC_Immune_SA) / Twitter
AC Immune: Old Theory, New Company (NASDAQ:ACIU) | Seeking Alpha
Who is AC Immune? A cutting-edge company with a robust pipeline
AC Immune picks up Phase 2-ready drug for Parkinson's in $58M deal with Affiris - MedCity News
AC Immune Announces Strategic Acquisition of
AC Immune Announces Strategic Acquisition of
AC Immune (@AC_Immune_SA) / Twitter
The Alzheimer's debate may not seem positive, but AC Immune's CEO promises it's been a breakthrough year | Fierce Biotech
AC Immune raises USD 43.5 million (CHF 42.7 million) in Financing Round E | Republic of Innovation
AC Immune (@AC_Immune_SA) / Twitter
AC Immune (@AC_Immune_SA) / Twitter
AC Immune acquires Parkinson's vaccine candidate
